Wedbush Reiterates Neutral, $54 Target on WEllCare Health Plans

Wedbush maintains its Neutral rating and $54 target price on WellCare Health Plans (NYSE: WCG) following Q4 results that beat estimates and consensus.

Wedbush notes, "We view WellCare as an attractive way to access Medicaid expansion. Risks to the attainment of our price target include high exposure to government businesses and the company's position as a price taker."

WCG closed at $62.96 a share yesterday.